199 related articles for article (PubMed ID: 32991522)
21. Reduced hippocampus volume and memory performance in bipolar disorder patients carrying the BDNF val66met met allele.
Cao B; Bauer IE; Sharma AN; Mwangi B; Frazier T; Lavagnino L; Zunta-Soares GB; Walss-Bass C; Glahn DC; Kapczinski F; Nielsen DA; Soares JC
J Affect Disord; 2016 Jul; 198():198-205. PubMed ID: 27018938
[TBL] [Abstract][Full Text] [Related]
22. The BDNF Val66Met polymorphism and plasma brain-derived neurotrophic factor levels in Han Chinese patients with bipolar disorder and schizophrenia.
Chen SL; Lee SY; Chang YH; Chen SH; Chu CH; Wang TY; Chen PS; Lee IH; Yang YK; Hong JS; Lu RB
Prog Neuropsychopharmacol Biol Psychiatry; 2014 Jun; 51():99-104. PubMed ID: 24468644
[TBL] [Abstract][Full Text] [Related]
23. Increased Risk-Taking Behaviour and Brain-Derived Neurotrophic Factor Val66Met Polymorphism Correlates to Decreased Serum Brain-Derived Neurotrophic Factor Level in Heroin Users.
Roviš D; Černelič Bizjak M; Vasiljev Marchesi V; Petelin A; Jenuš T; Vidic S; Drevenšek G; Jenko Pražnikar Z
Eur Addict Res; 2018; 24(4):189-200. PubMed ID: 30134233
[TBL] [Abstract][Full Text] [Related]
24. The relationship between dietary quality, serum brain-derived neurotrophic factor (BDNF) level, and the Val66met polymorphism in predicting depression.
Froud A; Murphy J; Cribb L; Ng CH; Sarris J
Nutr Neurosci; 2019 Jul; 22(7):513-521. PubMed ID: 29280414
[TBL] [Abstract][Full Text] [Related]
25. Association of the brain-derived neurotrophic factor val66met polymorphism with magnetic resonance spectroscopic markers in the human hippocampus: in vivo evidence for effects on the glutamate system.
Gruber O; Hasan A; Scherk H; Wobrock T; Schneider-Axmann T; Ekawardhani S; Schmitt A; Backens M; Reith W; Meyer J; Falkai P
Eur Arch Psychiatry Clin Neurosci; 2012 Feb; 262(1):23-31. PubMed ID: 21509595
[TBL] [Abstract][Full Text] [Related]
26. Relationship between neurotoxic kynurenine metabolites and reductions in right medial prefrontal cortical thickness in major depressive disorder.
Meier TB; Drevets WC; Wurfel BE; Ford BN; Morris HM; Victor TA; Bodurka J; Teague TK; Dantzer R; Savitz J
Brain Behav Immun; 2016 Mar; 53():39-48. PubMed ID: 26546831
[TBL] [Abstract][Full Text] [Related]
27. Meta-analysis of the BDNF Val66Met polymorphism in major depressive disorder: effects of gender and ethnicity.
Verhagen M; van der Meij A; van Deurzen PA; Janzing JG; Arias-Vásquez A; Buitelaar JK; Franke B
Mol Psychiatry; 2010 Mar; 15(3):260-71. PubMed ID: 18852698
[TBL] [Abstract][Full Text] [Related]
28. Association of serum BDNF level and Val66Met polymorphism with response to treatment in patients of major depressive disease: A step towards personalized therapy.
Pathak P; Mehra A; Ram S; Pal A; Grover S
Behav Brain Res; 2022 Jul; 430():113931. PubMed ID: 35605794
[TBL] [Abstract][Full Text] [Related]
29. Local gyrification index in patients with major depressive disorder and its association with tryptophan hydroxylase-2 (TPH2) polymorphism.
Han KM; Won E; Kang J; Kim A; Yoon HK; Chang HS; Son KR; Lee MS; Tae WS; Ham BJ
Hum Brain Mapp; 2017 Mar; 38(3):1299-1310. PubMed ID: 27807918
[TBL] [Abstract][Full Text] [Related]
30. Association between C-281A and val66met functional polymorphisms of BDNF gene and risk of recurrent major depressive disorder in Polish population.
Suchanek R; Owczarek A; Kowalczyk M; Kucia K; Kowalski J
J Mol Neurosci; 2011 Mar; 43(3):524-30. PubMed ID: 21103954
[TBL] [Abstract][Full Text] [Related]
31. Association of BDNF Val66Met Polymorphism and Brain BDNF Levels with Major Depression and Suicide.
Youssef MM; Underwood MD; Huang YY; Hsiung SC; Liu Y; Simpson NR; Bakalian MJ; Rosoklija GB; Dwork AJ; Arango V; Mann JJ
Int J Neuropsychopharmacol; 2018 Jun; 21(6):528-538. PubMed ID: 29432620
[TBL] [Abstract][Full Text] [Related]
32. Brain-derived neurotrophic factor gene Val66Met polymorphism and cognitive function in obsessive-compulsive disorder.
Tükel R; Gürvit H; Ozata B; Oztürk N; Ertekin BA; Ertekin E; Baran B; Kalem SA; Büyükgök D; Direskeneli GS
Am J Med Genet B Neuropsychiatr Genet; 2012 Oct; 159B(7):850-8. PubMed ID: 22911909
[TBL] [Abstract][Full Text] [Related]
33. Effect of childhood maltreatment and brain-derived neurotrophic factor on brain morphology.
van Velzen LS; Schmaal L; Jansen R; Milaneschi Y; Opmeer EM; Elzinga BM; van der Wee NJ; Veltman DJ; Penninx BW
Soc Cogn Affect Neurosci; 2016 Nov; 11(11):1841-1852. PubMed ID: 27405617
[TBL] [Abstract][Full Text] [Related]
34. Genetic variation in brain-derived neurotrophic factor val66met allele is associated with altered serotonin-1A receptor binding in human brain.
Lan MJ; Ogden RT; Huang YY; Oquendo MA; Sullivan GM; Miller J; Milak M; Mann JJ; Parsey RV
Neuroimage; 2014 Jul; 94():33-39. PubMed ID: 24607934
[TBL] [Abstract][Full Text] [Related]
35. Emotional fronto-cingulate cortex activation and brain derived neurotrophic factor polymorphism in premenstrual dysphoric disorder.
Comasco E; Hahn A; Ganger S; Gingnell M; Bannbers E; Oreland L; Wikström J; Epperson CN; Lanzenberger R; Sundström-Poromaa I
Hum Brain Mapp; 2014 Sep; 35(9):4450-8. PubMed ID: 24615932
[TBL] [Abstract][Full Text] [Related]
36. Met carriers of the BDNF Val66Met polymorphism show reduced Glx/NAA in the pregenual ACC in two independent cohorts.
Martens L; Herrmann L; Colic L; Li M; Richter A; Behnisch G; Stork O; Seidenbecher C; Schott BH; Walter M
Sci Rep; 2021 Mar; 11(1):6742. PubMed ID: 33762638
[TBL] [Abstract][Full Text] [Related]
37. Screening of brain-derived neurotrophic factor (BDNF) single nucleotide polymorphisms and plasma BDNF levels among Malaysian major depressive disorder patients.
Aldoghachi AF; Tor YS; Redzun SZ; Lokman KAB; Razaq NAA; Shahbudin AF; Badamasi IM; Cheah PS; Stanslas J; Veerakumarasivam A; Rosli R; Ibrahim N; Lye MS; Ling KH
PLoS One; 2019; 14(1):e0211241. PubMed ID: 30677092
[TBL] [Abstract][Full Text] [Related]
38. BDNF Val66Met polymorphism and hippocampal volume in neuropsychiatric disorders: A systematic review and meta-analysis.
Harrisberger F; Smieskova R; Schmidt A; Lenz C; Walter A; Wittfeld K; Grabe HJ; Lang UE; Fusar-Poli P; Borgwardt S
Neurosci Biobehav Rev; 2015 Aug; 55():107-18. PubMed ID: 25956254
[TBL] [Abstract][Full Text] [Related]
39. The cumulative effect of genetic polymorphisms on depression and brain structural integrity.
Kostic M; Canu E; Agosta F; Munjiza A; Novakovic I; Dobricic V; Maria Ferraro P; Miler Jerkovic V; Pekmezovic T; Lecic Tosevski D; Filippi M
Hum Brain Mapp; 2016 Jun; 37(6):2173-84. PubMed ID: 26956059
[TBL] [Abstract][Full Text] [Related]
40. Val66Met polymorphism and serum brain-derived neurotrophic factor in bipolar disorder: an open-label trial.
Grande I; Magalhães PV; Chendo I; Stertz L; Fries GR; Cereser KM; Cunha ÂB; Gói P; Kunz M; Udina M; Martín-Santos R; Frey BN; Vieta E; Kapczinski F
Acta Psychiatr Scand; 2014 May; 129(5):393-400. PubMed ID: 23957567
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
